Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMPHAS I
2013-002720-16Phase 4Completed
- Sponsor
- Stockholms Läns Sjukvårdsområde
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) and substance use disorder (SUD), sponsored by Stockholms Läns Sjukvårdsområde. Primary endpoint: Plasma concentrations of methylphenidate, its enantiomers, metabolites and concomitant drugs. Started Jun 2014; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)substance use disorder (SUD)
Beyond the preview
Go deeper on 2013-002720-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002720-16.